Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Fairwinds is stocked at 197 licensed dispensaries across Washington, with the deepest coverage in Seattle, Tacoma, Spokane, Vancouver, and Olympia. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, Fairwinds concentrated 48.9% of sales in Tincture & Sublingual, where sales declined 16.6% year over year but rose 11.6% month over month, while Vapor Pens held 25.1% share with a 14.0% year-over-year gain and a 2.8% month-over-month lift. Capsules at 13.2% share contracted 30.0% year over year and 10.1% month over month, and Topical at 11.1% share fell 8.5% year over year and 4.0% month over month; smaller lines like Concentrates (0.9% share) and Flower (0.8% share) posted deep year-over-year drops of 50.7% and 50.5% but climbed 15.0% and 13.8% month over month. With overall brand sales down 13.1% year over year alongside a 1.3% average price increase, the mix shift implies dependence on a declining lead category offset by incremental momentum in Vapor Pens and short-term rebounds in smaller segments.
The pattern points to a positioning anchored in Tincture & Sublingual—reinforced by a rank of 2 in Washington—while the 14.0% year-over-year growth in Vapor Pens and 2.8% month-over-month increase create a secondary engine that diversifies risk. Given Capsules’ 30.0% year-over-year decline and 10.1% month-over-month drop, and Topical’s 8.5% year-over-year and 4.0% month-over-month declines, the brand’s pricing uptick of 1.3% alongside category-specific contractions suggests a need to lean into formats with demonstrated velocity (Vapor Pens up 14.0% YoY) and to stabilize the core where month-over-month demand is recovering (Tincture & Sublingual up 11.6% MoM), implying a barbell strategy around a dominant flagship and a growing inhalable adjacency.
Competitive Landscape
Fairwinds sits at rank #2 in Washington Tincture & Sublingual for October 2026, unchanged YoY from #2, while slipping 1 position from #1 three months ago in July 2026; by contrast, Green Revolution held #1 both YoY and in October 2026 despite a -18.6% YoY sales change, and HiKu remained at #3 YoY and in October 2026 with a +41.7% YoY sales increase pressing upward. The stability at #2 alongside a drop from peak #1 in July 2026, combined with a leader showing double-digit contraction and a #3 competitor expanding by over 40%, implies Fairwinds’ current position is defensible near term but exposed to upward pressure from below more than displacement from the top.
Notable Products
Fairwinds leans on tinctures and a few adjacent formats in October 2026, with Tincture & Sublingual products accounting for 48.9% of sales and the top 10 items delivering 46.1%. The CBD/THC 5:1 Companion Savory Bacon 64x Tincture alone holds 11.6%, so most of its sales ride on a concentrated tincture lineup.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.






